Acute lymphoblastic leukaemia trials in France

In France 39 Also abroad 563

39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Asciminib Roll-over Study
Where
Bordeaux, Caen Cedex 9, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes Cedex 1, Nice, Paris, Poitiers, Strasbourg Cedex 2, Toulouse, Vandoeuvre Les Nancy
Age
7 years to 100 years
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Bordeaux, Lyon, Marseille, Nantes, Villejuif
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 2/3Taking people
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Where
Paris, Pessac
Age
12 years and over
People
340 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00
Phase 3Taking people
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Where
Amiens, ANGERS Cedex 09, Besancon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble cedex 09, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 05, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg Cedex 2, Toulouse, Tours, Vanoeuvre les Nancy
Age
1 year to 64 years
People
750 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00
Phase 2/3Taking people
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Where
Paris
Age
3 months to 25 years
People
1,000 worldwide
Run by
Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00
Phase 3Taking people
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Where
Amiens Cedex 1, Besancon Cedex, Bordeaux, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy
Age
1 day to 1 year
People
160 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00
Phase 3Taking people
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Where
Angers, La Roche-sur-Yon, Nantes, Rennes, Rouen
Age
18 years and over
People
63 worldwide
Run by
CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00
Phase 1/2Taking people
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Where
Caen, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse Cedex 9
Age
12 years and over
People
255 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00
Phase 1/2Taking people
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Where
Paris, Poitiers, Rennes
Age
1 year to 17 years
People
70 worldwide
Run by
Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00
Phase 1/2Taking people
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Where
Paris, Pessac, Pierre-Bénite, Villejuif
Age
30 days and over
People
447 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00
Phase 1/2Not yet taking people in France
Study of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
Where
Bordeaux, Lyon, Marseille, Nantes, Paris, Pessac, Rennes Cedex 9
Age
Up to 64 years
People
22 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-522019-40-00 · EU 2025-522019-40-00
Phase 2Taking people
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Where
Bordeaux, Lille, Lyon, Montpellier, Nantes, Nice, Paris, Rennes, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre lès Nancy
Age
1 year to 17 years
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00
Phase 2Taking people
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Where
Amiens, Angers, Besançon, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon, Nancy, Nantes, Nice, Paris, Pessac, Poitiers, Rouen, Saint-Etienne, Toulouse
Age
18 years and over
People
150
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT04935684
Phase 2/3Taking people
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Where
Bordeaux, Clermont-Ferrand, La Tronche, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Nantes, Paris, Rennes, Rouen Cedex, Strasbourg Cedex 2, Vandoeuvre Les Nancy Cedex
Age
1 month to 18 years
People
1,800 worldwide
Run by
St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00
No phaseTaking people
Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia
Where
Paris
Age
Up to 18 years
People
205
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07483476
Phase 3Taking people
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Where
Amiens Cedex 1, Angers, Besancon Cedex, Bordeaux, Brest, Caen Cedex 9, Clermont-Ferrand, Dijon, La Tronche, Lille Cedex, Limoges, Lyon Cedex 02, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Poitiers, Reims Cedex, Rennes, Rouen Cedex, Saint-Denis, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
Age
0 years to 45 years
People
6,430 worldwide
Run by
Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01
No phaseTaking people
EWALL-PH OBSERVARTORY 2022
Where
Amiens, Angers, Bayonne, Bordeaux, Clamart, Clermont-Ferrand, Corbeil-Essonnes, Grenoble, La Réunion, Le Chesnay, Le Mans, Lille, Marseille, Nancy, Nice, Paris, Pierre-Bénite, Saint-Etienne, Strasbourg, Toulouse
Age
18 years and over
People
100
Run by
Versailles Hospital
See details and how to joinNCT07684131
No phaseNot yet taking people in France
Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
Where
Nantes
Age
18 years and over
People
55
Run by
Nantes University Hospital
See details and how to joinNCT07249476
No phaseTaking people
Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies
Where
Montpellier
Age
18 years and over
People
300
Run by
University Hospital, Montpellier
See details and how to joinNCT04290000
Phase 2Not yet taking people in France
A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL
Where
Aix En Provence, Amiens Cedex 1, Angers, Argenteuil Cedex, Avignon, Bayonne, Besancon Cedex, Bobigny, Brest, Caen, Castelnauv Le Lez, Clamart, Clermont-Ferrand, Corbeil Essonnes Cedex, Creteil, Dijon, Dunkirk Cedex 1, Epagny Metz-tessy, Grenoble Cedex 09, Le Chesnay Rocquencourt, Lille Cedex, Limoges Cedex 1, Marseille, Metz Cedex 03, Montpellier Cedex 5, Mulhouse, Nantes, Nice, Nîmes, Orleans Cedex 2, Paris, Paris Cedex 12, Paris Cedex 13, Perpignan Cedex, Pessac, Pierre-Bénite, Poitiers, Reims Cedex, Rennes, Roubaix, Rouen, Saint-Priest-en-Jarez, Toulouse Cedex 9, Tours Cedex 9, Vandoeuvre Les Nancy, Villejuif
People
86 worldwide
Run by
Centre Hospitalier De Versailles
See details and how to join2024-516570-30-00 · EU 2024-516570-30-00
Phase 1/2Taking people
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia
Where
Lille Cedex, Lyon, Nantes, Nice, Paris, Toulouse Cedex 9
Age
Up to 17 years
People
142 worldwide
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504694-20-00 · EU 2023-504694-20-00
No phaseTaking people
Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital
Where
Nantes
Age
18 years and over
People
1,000
Run by
Nantes University Hospital
See details and how to joinNCT06681363
Phase 3Taking people
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
Where
Amiens Cedex 1, Angers, Besançon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, La Tronche, Lille Cedex, Limoges, Lyon, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Reims Cedex, Rennes, Rouen Cedex, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
Age
Up to 64 years
People
87 worldwide
Run by
Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 · EU 2025-520982-39-00
Phase 3Taking people
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Where
Bobigny Cedex, Le Chesnay Rocquencourt, Lyon, Nantes, Nice, Pessac, Pierre-Bénite, Poitiers, Toulouse Cedex 9
Age
18 years and over
People
350 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00
No phaseNot yet taking people in France
Role of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.
Where
Marseille, Nice
Age
1 year to 99 years
People
20
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07529223